Prostate-specific Antigen Current Events | Prostate-specific Antigen News
|
| Page
1 of
32 |
637 Results |
|
|
|
Sort By:
Page Views | Date |
Prostate specific antigen: A review of PSA use in screening for prostate cancer
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America. view more (2007-06-19)
Annual prostate cancer screening test appears to save lives
Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings. view more (2005-10-20)
PSA velocity's clinical usefulness remains unclear
Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool. view more (2007-10-10)
Anti-inflammatory drugs may mask prostate cancer marker
Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, may reduce serum levels of the prostate biomarker, PSA (prostate specific antigen), and hence may alter the detection of prostate cancer in individuals who take these medications. view more (2008-09-08)
Prostate cancer gene test provides new early detection
Prostate cancer (PCa) is one of the most common male cancers in the Western world. Currently, early detection of PCa depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses. view more (2008-10-17)
U-M researchers identify new blood test for prostate cancer
Researchers at the University of Michigan Comprehensive Cancer Center have identified a panel of 22 biomarkers that together provide a more accurate screening for prostate cancer than the current prostate specific antigen, or PSA, test. view more (2005-09-22)
PSA predicts treatment success in advanced prostate cancer
A test used to detect prostate cancer can also help doctors know when treatment is working. view more (2006-08-24)
PSA doubling predicts prostate cancer recurrence
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time (DT) is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for... view more... (2007-04-10)
PSA test has higher accuracy for patients taking finasteride
Finasteride is a drug prescribed for men whose prostates have become enlarged. The drug decreases prostate swelling and helps men with urinary problems. view more (2006-08-16)
University of Kent Study Aims To Improve Information And Support Needs For Older Men With Prostate Cancer
The Centre for Health Services Studies (CHSS) at the University of Kent is currently engaged in an exploratory study of the information and support needs for men aged 75+ with prostate cancer. view more (2004-11-03)
New finding suggests prostate biopsy is not always necessary
Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy. view more (2009-11-09)
Prostate cancer vaccines more effective with hormone therapy
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for... view more... (2008-07-10)
Men with prostate cancer want screening despite doubts over effectiveness of treatment
Most men with prostate cancer strongly advocate routine testing for prostate specific antigen (PSA), despite evidence that aggressive screening and treatment does not reduce deaths, according to two studies in this week's BMJ. In the first study, researchers at the University of Oxford interviewed 52 men with suspected or confirmed prostate... view more... (2002-10-02)
Early warning: PSA testing can predict advanced prostate cancer
Researchers who showed that a single prostate specific antigen (PSA) test at age 50 or under could predict the presence of prostate cancer up to 25 years later, (regardless of clinical significance) have now found that a single PSA can be used to predict advanced prostate cancer. view more (2008-02-15)
MR imaging accurately determines prostate cancer treatment failure
Dynamic contrast-enhanced MRI (DCE-MRI) plus diffusion weighted imaging (DWI) can accurately diagnose residual or recurrent prostate cancer in patients treated with high-intensity focused ultrasonic ablation, a new study shows. view more (2008-05-20)
Routine evaluation of prostate size not as effective in cancer screening, Mayo study finds
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. view more (2009-11-11)
Largest PSA bounce study eases worry of prostate cancer returning
Prostate cancer patients who have a temporary rise in their prostate specific antigen (PSA) levels after radiation therapy-called a PSA bounce-are not at an increased risk of their cancer coming back any more than those who don't have a temporary rise. view more (2006-11-09)
OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer
Oregon Health & Science University Cancer Institute researchers, in a first-of-its-kind study, have found that even men with advanced prostate cancer can take a much-needed safe break, or holiday, from chemotherapy. view more (2008-02-26)
New classification better identifies prostate cancer patients to benefit from hormone therapy
A new classification system for evaluating men after radiation treatment for prostate cancer better determines which men may recur and thus may benefit from hormone therapy. view more (2006-11-09)
Speed of PSA rise helps predict survival for prostate cancer patients
The clinical outcome for prostate cancer patients who have been treated with hormone therapy and radiation therapy can usually be determined by how rapidly their prostate specific antigen level rises following treatment. view more (2005-10-03)
|
|
| Page
1 of
32 |
637 Results |
|
|
|
Sort By:
Page Views | Date |
|
